role of glutathione in cancer progression and chemoresistance Frontiers Living on the Edge: ROS

doi:10.1016/S0165-0327(97)00166-3

As of mid-2025, no Phase II or Phase III human clinical trial for BPC-157 has been completed and published in a peer-reviewed journal

Therefore, in order to overcome the survival crisis caused by oxidative stress, cancer cells are likely to exhibit metabolic preferences and undergo metabolic reprogramming, including but not limited to GSH metabolic rewiring

Preliminary studies suggest that inhibiting ferroptosis may offer protective effects on ovarian function, although the translational relevance of these findings remains to be established

X39 patches are intended to support general wellness only and are not designed to treat, cure, or prevent any condition